J.P. Marvel Investment Advisors LLC Decreases Position in Danaher Co. (NYSE:DHR)

J.P. Marvel Investment Advisors LLC lowered its stake in shares of Danaher Co. (NYSE:DHR) by 0.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,180 shares of the conglomerate’s stock after selling 105 shares during the quarter. Danaher accounts for about 1.6% of J.P. Marvel Investment Advisors LLC’s portfolio, making the stock its 19th largest position. J.P. Marvel Investment Advisors LLC’s holdings in Danaher were worth $9,503,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. nVerses Capital LLC purchased a new stake in shares of Danaher in the 2nd quarter valued at approximately $25,000. CarsonAllaria Wealth Management Ltd. purchased a new position in Danaher in the second quarter valued at $25,000. MFA Wealth Advisors LLC purchased a new position in Danaher in the second quarter valued at $51,000. Financial Connections Group Inc. purchased a new stake in Danaher during the 2nd quarter worth about $51,000. Finally, Western Pacific Wealth Management LP acquired a new position in shares of Danaher during the 1st quarter worth about $55,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Stifel Nicolaus boosted their target price on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Raymond James lowered their target price on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Royal Bank of Canada dropped their target price on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. The Goldman Sachs Group boosted their price target on shares of Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Finally, StockNews.com raised Danaher from a “hold” rating to a “buy” rating in a report on Wednesday. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $287.16.

Danaher Stock Performance

NYSE:DHR opened at $246.10 on Friday. The firm has a market cap of $177.75 billion, a price-to-earnings ratio of 46.97, a price-to-earnings-growth ratio of 4.54 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a 1-year low of $192.35 and a 1-year high of $281.70. The firm’s fifty day moving average price is $265.79 and its 200 day moving average price is $260.75.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same period in the prior year, the company posted $2.02 earnings per share. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. On average, sell-side analysts expect that Danaher Co. will post 7.51 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Insider Buying and Selling

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 10.90% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.